Hemangioblastoma pathogenesis is believed to be secondary to dysregulation of the HIF pathway with inappropriate elevation of HIF-1a leading to increased expression of erythropoietin and vascular endothelial growth factor [36, 37]. Here, EPO is linked to hemangioblastoma.